Cheukfai Li

530 total citations
26 papers, 307 citations indexed

About

Cheukfai Li is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Cheukfai Li has authored 26 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cancer Research, 11 papers in Oncology and 10 papers in Molecular Biology. Recurrent topics in Cheukfai Li's work include Cancer Genomics and Diagnostics (6 papers), Breast Cancer Treatment Studies (5 papers) and Advanced Breast Cancer Therapies (4 papers). Cheukfai Li is often cited by papers focused on Cancer Genomics and Diagnostics (6 papers), Breast Cancer Treatment Studies (5 papers) and Advanced Breast Cancer Therapies (4 papers). Cheukfai Li collaborates with scholars based in China, United States and Spain. Cheukfai Li's co-authors include Chongyang Ren, Guochun Zhang, Lingzhu Wen, Li Cao, Bo Chen, Hsiaopei Mok, Jiali Lin, Guangnan Wei, Minghan Jia and Yulei Wang and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Cellular Physiology and Transplantation.

In The Last Decade

Cheukfai Li

25 papers receiving 304 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cheukfai Li China 9 143 141 126 66 49 26 307
Laura Arthur United Kingdom 9 153 1.1× 139 1.0× 102 0.8× 74 1.1× 18 0.4× 21 271
Nicoletta Provinciali Italy 9 175 1.2× 119 0.8× 83 0.7× 54 0.8× 23 0.5× 22 308
Elliana Young United States 6 152 1.1× 132 0.9× 92 0.7× 56 0.8× 34 0.7× 10 253
Annette Raskov Kodahl Denmark 10 89 0.6× 248 1.8× 204 1.6× 74 1.1× 48 1.0× 20 361
Thorsten Gutjahr United Kingdom 6 209 1.5× 58 0.4× 106 0.8× 54 0.8× 121 2.5× 10 297
Junjie Li China 10 99 0.7× 98 0.7× 68 0.5× 45 0.7× 38 0.8× 28 234
Ji Won Woo South Korea 10 219 1.5× 118 0.8× 82 0.7× 58 0.9× 89 1.8× 18 352
Jelmar Quist United Kingdom 10 102 0.7× 72 0.5× 127 1.0× 39 0.6× 14 0.3× 22 259
Asona Lui United States 10 110 0.8× 80 0.6× 157 1.2× 94 1.4× 31 0.6× 21 333
Xiaolong Liang China 12 99 0.7× 144 1.0× 179 1.4× 52 0.8× 44 0.9× 36 381

Countries citing papers authored by Cheukfai Li

Since Specialization
Citations

This map shows the geographic impact of Cheukfai Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheukfai Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheukfai Li more than expected).

Fields of papers citing papers by Cheukfai Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheukfai Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheukfai Li. The network helps show where Cheukfai Li may publish in the future.

Co-authorship network of co-authors of Cheukfai Li

This figure shows the co-authorship network connecting the top 25 collaborators of Cheukfai Li. A scholar is included among the top collaborators of Cheukfai Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheukfai Li. Cheukfai Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Liao, Ning, Cheukfai Li, Li Cao, et al.. (2022). Single-cell profile of tumor and immune cells in primary breast cancer, sentinel lymph node, and metastatic lymph node. Breast Cancer. 30(1). 77–87. 3 indexed citations
3.
Cao, Li, Chongyang Ren, Guochun Zhang, et al.. (2022). Characteristics of MYC Amplification and Their Association with Clinicopathological and Molecular Factors in Patients with Breast Cancer. DNA and Cell Biology. 41(5). 521–538. 5 indexed citations
4.
Zhang, Yuchen, Cheukfai Li, Chenglai Xia, et al.. (2022). Adagrasib, a KRAS G12C inhibitor, reverses the multidrug resistance mediated by ABCB1 in vitro and in vivo. Cell Communication and Signaling. 20(1). 142–142. 24 indexed citations
5.
Guo, Yanhui, et al.. (2022). Using an Improved Residual Network to Identify PIK3CA Mutation Status in Breast Cancer on Ultrasound Image. Frontiers in Oncology. 12. 850515–850515. 8 indexed citations
6.
Li, Yingzi, Bo Chen, Xiaoyi Lin, et al.. (2022). Clinicopathologic and Genomic Features in Triple-Negative Breast Cancer Between Special and No-Special Morphologic Pattern. Frontiers in Oncology. 12. 830124–830124. 4 indexed citations
7.
Li, Cheukfai, Chongyang Ren, Lingzhu Wen, et al.. (2022). Heterogenous and Low Expression of HER2 in Breast Cancer Overcome by DS-8201a in a Heavily Treated Patient: Case Report and Review of the Literature. Clinical Medicine Insights Oncology. 16. 1353193840–1353193840. 1 indexed citations
8.
Li, Cheukfai, Chuanzhao Zhang, Guochun Zhang, et al.. (2022). YTHDF1 amplification is correlated with worse outcome and lower immune cell infiltrations in breast cancer. Cancer Biomarkers. 35(2). 127–142. 9 indexed citations
9.
Zhang, Guochun, Chongyang Ren, Cheukfai Li, et al.. (2022). Distinct clinical and somatic mutational features of breast tumors with high-, low-, or non-expressing human epidermal growth factor receptor 2 status. BMC Medicine. 20(1). 142–142. 90 indexed citations
10.
Jia, Minghan, Ning Liao, Bo Chen, et al.. (2021). PIK3CA somatic alterations in invasive breast cancers: different spectrum from Caucasians to Chinese detected by next generation sequencing. Breast Cancer. 28(3). 644–652. 8 indexed citations
11.
Wen, Lingzhu, Guochun Zhang, Chongyang Ren, et al.. (2021). Characterization of AKT Somatic Mutations in Chinese Breast Cancer Patients. Cancer Management and Research. Volume 13. 3055–3065. 5 indexed citations
12.
Chen, Bo, Liping Guo, Kai Li, et al.. (2021). Association of Body Mass Index With Somatic Mutations in Breast Cancer. Frontiers in Oncology. 11. 613933–613933. 1 indexed citations
13.
Chen, Bo, Guochun Zhang, Guangnan Wei, et al.. (2020). Heterogeneity of genomic profile in patients with HER2-positive breast cancer. Endocrine Related Cancer. 27(3). 153–162. 26 indexed citations
14.
Chen, Bo, Guochun Zhang, Xuerui Li, et al.. (2020). Comparison of BRCA versus non-BRCA germline mutations and associated somatic mutation profiles in patients with unselected breast cancer. Aging. 12(4). 3140–3155. 36 indexed citations
15.
Yu, Weixuan, Dongwei Li, Yunda Zhang, et al.. (2019). MiR-142-5p Acts as a Significant Regulator Through Promoting Proliferation, Invasion, and Migration in Breast Cancer Modulated by Targeting SORBS1. Technology in Cancer Research & Treatment. 18. 1078159912–1078159912. 31 indexed citations
16.
Zhang, Qianqian, et al.. (2018). Let‐7e inhibits TNF‐α expression by targeting the methyl transferase EZH2 in DENV2‐infected THP‐1 cells. Journal of Cellular Physiology. 233(11). 8605–8616. 18 indexed citations
17.
Chen, Maogen, et al.. (2018). Advances in T follicular helper and T follicular regulatory cells in transplantation immunity. Transplantation Reviews. 32(4). 187–193. 11 indexed citations
18.
Ju, Weiqiang, Cheukfai Li, Chuanzhao Zhang, et al.. (2018). Outcome of the use of paediatric donor livers in adult recipients: A single Chinese centre experience. Clinics and Research in Hepatology and Gastroenterology. 43(2). 148–154. 3 indexed citations
19.
Huang, Jiefu, Cheukfai Li, Zhiyong Guo, & Xiaoshun He. (2017). The development history of organ donation in China. 3(2). 81–84. 3 indexed citations
20.
Li, Cheukfai, et al.. (2017). Expression of lncRNA-AK005641 in Murine CD4+FOXP3+Treg and iTreg Differentiation. Transplantation. 101(5S-3). S4–S4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026